Trial Profile
Skin Transcriptional Profiles In Psoriatic Patients Under Adalimumab Biotherapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Oct 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Plaque psoriasis
- Focus Biomarker; Therapeutic Use
- Acronyms CYTOPSO
- 10 Oct 2016 Status changed from recruiting to completed.
- 27 Jun 2013 New trial record